Common Contracts
3 similar Separation and Consulting Agreement contracts by Myriad Genetics Inc
SEPARATION AND CONSULTING AGREEMENT AND RELEASE OF CLAIMSSeparation and Consulting Agreement • February 28th, 2024 • Myriad Genetics Inc • In vitro & in vivo diagnostic substances • Utah
This Separation and Consulting Agreement and Release of Claims (“Agreement”), dated as of December 15, 2023, is entered into by and between Myriad Genetics, Inc. (together with its subsidiaries, affiliates, successors and assigns, the “Company”) and R. Bryan Riggsbee (“Executive” and together with the Company, the “Parties” and each a “Party”).
SEPARATION AND CONSULTING AGREEMENT AND RELEASE OF CLAIMSSeparation and Consulting Agreement • February 28th, 2024 • Myriad Genetics Inc • In vitro & in vivo diagnostic substances • Utah
This Separation and Consulting Agreement and Release of Claims (“Agreement”), dated as of October 4, 2023, is entered into by and between Myriad Genetics, Inc. (together with its subsidiaries, affiliates, successors and assigns, the “Company”) and Nicole Lambert (“Executive” and together with the Company, the “Parties” and each a “Party”).
SEPARATION AND CONSULTING AGREEMENT AND RELEASE OF CLAIMSSeparation and Consulting Agreement • October 5th, 2023 • Myriad Genetics Inc • In vitro & in vivo diagnostic substances • Utah
This Separation and Consulting Agreement and Release of Claims (“Agreement”), dated as of October 4, 2023, is entered into by and between Myriad Genetics, Inc. (together with its subsidiaries, affiliates, successors and assigns, the “Company”) and Nicole Lambert (“Executive” and together with the Company, the “Parties” and each a “Party”).
